DOCS Stoklara Genel Bakış
Doximity, Inc. Amerika Birleşik Devletleri'ndeki tıp uzmanları için bulut tabanlı bir dijital platform işletmektedir.
Kar Tanesi Skoru | |
---|---|
Değerleme | 1/6 |
Gelecekteki Büyüme | 1/6 |
Geçmiş Performans | 4/6 |
Finansal Sağlık | 6/6 |
Temettüler | 0/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Doximity, Inc. Rakipler
Fiyat Geçmişi ve Performans
Tarihsel hisse senedi fiyatları | |
---|---|
Güncel Hisse Fiyatı | US$42.35 |
52 Haftanın En Yüksek Seviyesi | US$44.88 |
52 Haftanın En Düşük Seviyesi | US$20.28 |
Beta | 1.29 |
11 Aylık Değişim | -3.38% |
3 Aylık Değişim | 61.33% |
1 Yıllık Değişim | 98.83% |
33 Yıllık Değişim | -40.39% |
5 Yıllık Değişim | n/a |
Halka arzdan bu yana değişim | -20.09% |
Son Haberler & Güncellemeler
Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?
Nov 02Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 15Doximity: Downgrade To Hold On Valuation Concerns
Oct 03Recent updates
Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?
Nov 02Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 15Doximity: Downgrade To Hold On Valuation Concerns
Oct 03Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
Sep 23There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump
Aug 18Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns
Aug 10Doximity Faces Slower Revenue Growth As R&D Costs May Rise
Jul 23Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?
Jul 23At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?
Jul 01Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking
Jun 09Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)
May 17Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal
May 04Doximity: Significant Upside Remains, But Not Until The Growth Story Returns
Apr 29With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For
Apr 16Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Mar 26Doximity: Rating Upgrade To Buy As Outlook Turns Positive
Feb 21We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit
Feb 15What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?
Feb 13Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan
Jan 16Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital
Jan 04Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price
Dec 14Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism
Nov 10Doximity: Adding Value Using AI But Faces Near-Term Risks
Nov 01Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?
Oct 30Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively
Sep 25Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook
Aug 24Doximity Earnings: Too Many Problems, Sell
Aug 09A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)
Jul 29Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching
Jul 09Doximity: Continue To See Positive Upside From Current Stock Level
Jul 05The Returns At Doximity (NYSE:DOCS) Aren't Growing
Jun 21Doximity: Digital Health Play With Strong Fundamentals
Jun 21A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Apr 07Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return
Mar 20Doximity: Good Business But Extremely Overvalued
Feb 18Doximity Q3 Earnings: Disappointing Results
Feb 10Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Dec 25Doximity: On The Right Path To Further Consolidate Market Share
Dec 22Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital
Dec 04Hissedar Getirileri
DOCS | US Healthcare Services | US Pazar | |
---|---|---|---|
7D | 2.2% | 0.4% | -1.6% |
1Y | 98.8% | 2.4% | 30.8% |
Getiri vs. Endüstri: DOCS exceeded the US Healthcare Services industry which returned 2% over the past year.
Getiri vs Piyasa: DOCS exceeded the US Market which returned 30.6% over the past year.
Fiyat Oynaklığı
DOCS volatility | |
---|---|
DOCS Average Weekly Movement | 11.4% |
Healthcare Services Industry Average Movement | 8.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 2.9% |
İstikrarlı Hisse Senedi Fiyatı: DOCS's share price has been volatile over the past 3 months compared to the US market.
Zaman İçindeki Volatilite: DOCS's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
Şirket Hakkında
Kuruldu | Çalışanlar | CEO | Web sitesi |
---|---|---|---|
2010 | 827 | Jeff Tangney | www.doximity.com |
Doximity, Inc. Amerika Birleşik Devletleri'ndeki tıp uzmanları için bulut tabanlı bir dijital platform işletmektedir. Şirketin platformu, üyelerine meslektaşlarıyla işbirliği yapmalarını, en son tıbbi haberleri ve araştırmaları takip etmelerini, kariyerlerini ve nöbet programlarını yönetmelerini, dokümantasyon ve idari evrak işlerini kolaylaştırmalarını ve sanal hasta ziyaretleri gerçekleştirmelerini sağlayan tıp için oluşturulmuş dijital araçlar sunmaktadır. Öncelikle doktorlara, pratisyen hemşirelere, doktor asistanlarına, tıp öğrencilerine, ilaç üreticilerine ve sağlık sistemlerine hizmet vermektedir.
Doximity, Inc. Temel Bilgiler Özeti
DOCS temel i̇stati̇sti̇kler | |
---|---|
Piyasa değeri | US$7.86b |
Kazançlar(TTM) | US$160.55m |
Gelir(TTM) | US$493.63m |
49.0x
F/K Oranı15.9x
P/S OranıDOCS aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
DOCS gelir tablosu (TTM) | |
---|---|
Gelir | US$493.63m |
Gelir Maliyeti | US$51.07m |
Brüt Kâr | US$442.56m |
Diğer Giderler | US$282.01m |
Kazançlar | US$160.55m |
Son Raporlanan Kazançlar
Jun 30, 2024
Sonraki Kazanç Tarihi
Nov 07, 2024
Hisse başına kazanç (EPS) | 0.86 |
Brüt Marj | 89.66% |
Net Kâr Marjı | 32.53% |
Borç/Özkaynak Oranı | 0% |
DOCS uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görün